modafinil has been researched along with flecainide in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (14.29) | 29.6817 |
| 2010's | 5 (71.43) | 24.3611 |
| 2020's | 1 (14.29) | 2.80 |
| Authors | Studies |
|---|---|
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Choi, SS; Contrera, JF; Hastings, KL; Kruhlak, NL; Sancilio, LF; Weaver, JL; Willard, JM | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Charvériat, M; Chauveau, F; Dauvilliers, Y; Duchêne, A; Giaume, C; Jeanson, T; Lagarde, D; Lin, JS; Liu, X; Mouthon, F; Perier, M; Picoli, C; Piérard, C; Thomasson, J; Zhao, Y | 1 |
| Charvériat, M; Dauvilliers, Y; Duchêne, A; Giaume, C; Leroy, C; Lin, JS; Mouthon, F; Pottier, G; Tournier, N; Vodovar, D; Wimberley, C | 1 |
| Arnal, P; Bougard, C; Bourrrilhon, C; Brunner-Ferber, F; Charvériat, M; Chennaoui, M; Dauvilliers, Y; Drogou, C; Dubourdieu, D; Erblang, M; Gomez-Merino, D; Guillard, M; Lefloch, H; Leger, D; Mouthon, F; Rabat, A; Rein, W; Sauvet, F; Van Beers, P | 1 |
| Azulay, JP; Bosse, B; Corvol, JC; Dauvilliers, Y; Defebvre, L; Klostermann, F; Kovacs, N; Maltête, D; Ondo, WG; Pahwa, R; Rascol, O; Rein, W; Thobois, S; Valis, M; Videnovic, A | 1 |
1 review(s) available for modafinil and flecainide
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
2 trial(s) available for modafinil and flecainide
| Article | Year |
|---|---|
Efficacy of THN102 (a combination of modafinil and flecainide) on vigilance and cognition during 40-hour total sleep deprivation in healthy subjects: Glial connexins as a therapeutic target.
Topics: Adult; Arousal; Cognition; Connexins; Cross-Over Studies; Drug Combinations; Flecainide; Healthy Volunteers; Humans; Male; Memory, Short-Term; Modafinil; Neuroglia; Psychomotor Performance; Reaction Time; Sleep Deprivation; Treatment Outcome; Wakefulness; Wakefulness-Promoting Agents; Young Adult | 2019 |
THN 102 for Excessive Daytime Sleepiness Associated with Parkinson's Disease: A Phase 2a Trial.
Topics: Disorders of Excessive Somnolence; Double-Blind Method; Drug Combinations; Flecainide; Humans; Modafinil; Parkinson Disease | 2022 |
4 other study(ies) available for modafinil and flecainide
| Article | Year |
|---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models.
Topics: | 2008 |
Impact of Astroglial Connexins on Modafinil Pharmacological Properties.
Topics: Animals; Astrocytes; Benzhydryl Compounds; Connexin 30; Connexin 43; Connexins; Disease Models, Animal; Flecainide; Male; Meclofenamic Acid; Mice; Mice, Knockout; Modafinil; Narcolepsy; Orexins; Sleep; Wakefulness | 2016 |
Cortico-Amygdala-Striatal Activation by Modafinil/Flecainide Combination.
Topics: Amygdala; Animals; Cerebral Cortex; Corpus Striatum; Drug Combinations; Flecainide; Fluorodeoxyglucose F18; Male; Modafinil; Positron-Emission Tomography; Rats; Rats, Sprague-Dawley; Voltage-Gated Sodium Channel Blockers; Wakefulness-Promoting Agents | 2018 |